Characterizing antibodies for cancer research
Proteomic and Antibody Production and Characterization
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10929918
This study is looking at how antibodies work in cancer treatment to help create better tests and therapies for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10929918 on ClinicalTrials.gov |
What this research studies
This research focuses on the comprehensive characterization of antibodies used in cancer research through advanced techniques like Mass Spectrometry. The Antibody Characterization Laboratory at the National Cancer Institute will establish a Proteomic Characterization Laboratory to analyze proteins and their interactions in cancer. By developing targeted assays, the research aims to improve the understanding of antibody responses and their role in cancer treatment. Patients may benefit from enhanced diagnostic and therapeutic tools derived from this work.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who may benefit from improved antibody-based therapies.
Not a fit: Patients with non-cancerous conditions or those not involved in antibody-based treatments may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer diagnostics and treatments through better understanding of antibody interactions.
How similar studies have performed: Other research in antibody characterization and proteomics has shown promise in improving cancer treatment strategies, indicating a potential for success in this approach.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DMITROVSKY, ETHAN — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: DMITROVSKY, ETHAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.